- Home
- APLT vs GGT Comparison
APLT vs GGT Comparison
Compare APLT & GGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APLT
- GGT
- Stock Information
- Founded
- APLT 2016
- GGT 1994
- Country
- APLT United States
- GGT United States
- Employees
- APLT N/A
- GGT N/A
- Industry
- APLT Biotechnology: Pharmaceutical Preparations
- GGT Trusts Except Educational Religious and Charitable
- Sector
- APLT Health Care
- GGT Finance
- Exchange
- APLT Nasdaq
- GGT Nasdaq
- Market Cap
- APLT 140.8M
- GGT 136.5M
- IPO Year
- APLT 2019
- GGT N/A
- Fundamental
- Price
- APLT $1.10
- GGT $4.65
- Analyst Decision
- APLT Buy
- GGT
- Analyst Count
- APLT 6
- GGT 0
- Target Price
- APLT $6.60
- GGT N/A
- AVG Volume (30 Days)
- APLT 10.8M
- GGT 59.7K
- Earning Date
- APLT 11-07-2024
- GGT 01-01-0001
- Dividend Yield
- APLT N/A
- GGT 15.56%
- EPS Growth
- APLT N/A
- GGT N/A
- EPS
- APLT N/A
- GGT 0.83
- Revenue
- APLT N/A
- GGT N/A
- Revenue This Year
- APLT N/A
- GGT N/A
- Revenue Next Year
- APLT $5,117.00
- GGT N/A
- P/E Ratio
- APLT N/A
- GGT $6.90
- Revenue Growth
- APLT N/A
- GGT N/A
- 52 Week Low
- APLT $1.03
- GGT $4.32
- 52 Week High
- APLT $10.62
- GGT $7.00
- Technical
- Relative Strength Index (RSI)
- APLT 17.64
- GGT 31.54
- Support Level
- APLT $1.03
- GGT $4.64
- Resistance Level
- APLT $1.37
- GGT $5.12
- Average True Range (ATR)
- APLT 0.33
- GGT 0.06
- MACD
- APLT -0.15
- GGT -0.05
- Stochastic Oscillator
- APLT 0.75
- GGT 2.04
About APLT Applied Therapeutics Inc.
Applied Therapeutics Inc is a clinical-stage biopharmaceutical company, developing a pipeline of novel product candidates against validated molecular targets in indications of high unmet medical need. The company's drug compounds pipeline includes, AT-007 which is a novel central nervous system, penetrant ARI that it is developing for the treatment of rare metabolic diseases, including Galactosemia and Sorbitol Dehydrogenase (SORD) Deficiency, AT-001 for the treatment of diabetic cardiomyopathy, and AT-003 for the treatment of diabetic retinopathy.
About GGT Gabelli Multi-Media Trust Inc. (The)
Gabelli Multimedia Trust Inc is a non-diversified closed-end management investment company. Its investment objective is the long-term growth of capital with income as a secondary objective. The fund invests majority of its assets, under normal market conditions, in common stock and other securities, including convertible securities, preferred stock, options, and warrants of companies in the telecommunications, media, publishing, and entertainment industries.